Literature DB >> 6615808

Purification and some physicochemical properties of toxic-shock toxin.

R F Reiser, R N Robbins, G P Khoe, M S Bergdoll.   

Abstract

A procedure for the purification of a protein marker for the staphylococci isolated from toxic-shock syndrome patients has been developed. The purification procedure involves the removal of the toxic protein from culture supernatant fluids of toxic-shock syndrome associated Staphylococcus aureus strains FRI-1169 and FRI-1183 by batch absorption with CG-50 resin, ion-exchange chromatography on CM-Sepharose CL-6B, and gel permeation chromatography on Sephacryl S-200. The purified toxin is a simple protein with a molecular weight of 24 000 +/- 500 as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The isoelectric point of the major band is 7.0 as determined by isoelectric focusing in polyacrylamide gels. The TS-toxin's reactivity with its specific antibody is not affected by tryptic digestion at pH 8.0 but is slowly reduced by treatment with pepsin at pH 4.5. The TS-toxin consists of 188 amino acid residues. Serine was shown to be the NH2-terminal amino acid residue by end-group analysis. Initial studies indicated the protein was emetic; thus tentatively it was called staphylococcal enterotoxin F. In this paper it is called TS-toxin because the emetic action in monkeys has not been confirmed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615808     DOI: 10.1021/bi00285a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus.

Authors:  A C Wong; M S Bergdoll
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

2.  Ovine-associated Staphylococcus aureus protein with immunochemical similarity to toxic shock syndrome toxin 1.

Authors:  G Ho; W H Campbell; E Carlson
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Effect of chemical modification of histidine and tyrosine residues in toxic shock syndrome toxin 1 on the serologic and mitogenic activities of the toxin.

Authors:  N P Kokan-Moore; M S Bergdoll
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Latex agglutination test for staphylococcal toxic shock syndrome toxin 1.

Authors:  H Igarashi; H Fujikawa; M Shingaki; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

5.  Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.

Authors:  B Christensson; P J Johansson; V A Oxelius
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

6.  Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.

Authors:  A C Lee; B A Crass; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

7.  Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model.

Authors:  J C de Azavedo; T J Foster; P J Hartigan; J P Arbuthnott; M O'Reilly; B N Kreiswirth; R P Novick
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Studies on staphylococci from toxic shock syndrome in France, 1981-1983.

Authors:  A K Melconian; J Fleurette; Y Brun
Journal:  J Hyg (Lond)       Date:  1985-02

9.  Association of high levels of serum antibody to staphylococcal toxic shock antigen with nasal carriage of toxic shock antigen-producing strains of Staphylococcus aureus.

Authors:  H L Ritz; J J Kirkland; G G Bond; E K Warner; G P Petty
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

10.  Toxin involvement in methicillin-resistant Staphylococcus aureus enteritis in gastroenterological surgery.

Authors:  Y Takesue; T Yokoyama; T Kodama; T Santou; A Nakamitsu; Y Murakami; Y Imamura; K Miyamoto; M Okita; H Tsumura
Journal:  Gastroenterol Jpn       Date:  1991-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.